Literature DB >> 3109545

Relation between phenotype and banal melanocytic naevi.

J S English, A J Swerdlow, R M MacKie, C J O'Doherty, J A Hunter, J Clark, D J Hole.   

Abstract

In a study of risk factors for the development of melanocytic naevi in relation to the pathogenesis of malignant melanoma 197 white adults were examined by four dermatologists and naevus counts correlated with several other features. Highly significant associations were found between large numbers of banal acquired melanocytic naevi and the ability to tan easily without burning (skin types 3 and 4; relative risk 4.6), brown or hazel eyes (relative risk 3.5), green or grey eyes (relative risk 3.5) and brown or black hair (relative risk 3.7). No significant associations with numbers of naevi were shown for parity or use of oral contraceptives or other steroid hormones. This is the first study to find any relation between melanocytic naevi and phenotypic factors in a white population.

Entities:  

Mesh:

Year:  1987        PMID: 3109545      PMCID: PMC1245163          DOI: 10.1136/bmj.294.6565.152

Source DB:  PubMed          Journal:  Br Med J (Clin Res Ed)        ISSN: 0267-0623


  18 in total

1.  Effect of corticotropin and cortisone on development and progress of pigmented nevi.

Authors:  L GOLDMAN; D F RICHFIELD
Journal:  J Am Med Assoc       Date:  1951-11-03

2.  Pigmented lesions in newborn infants.

Authors:  R G Walton; A H Jacobs; A J Cox
Journal:  Br J Dermatol       Date:  1976-10       Impact factor: 9.302

3.  Benign melanocytic naevi as a risk factor for malignant melanoma.

Authors:  A J Swerdlow; J English; R M MacKie; C J O'Doherty; J A Hunter; J Clark; D J Hole
Journal:  Br Med J (Clin Res Ed)       Date:  1986-06-14

4.  Genetic susceptibility and somatic mutation in the production of freckles, birthmarks and moles.

Authors:  E M Nicholls
Journal:  Lancet       Date:  1968-01-13       Impact factor: 79.321

5.  Development and elimination of pigmented moles, and the anatomical distribution of primary malignant melanoma.

Authors:  E M Nicholls
Journal:  Cancer       Date:  1973-07       Impact factor: 6.860

6.  Epidemiology of congenital pigmented naevi: I. Incidence rates and relative frequencies.

Authors:  E E Castilla; M da Graça Dutra; I M Orioli-Parreiras
Journal:  Br J Dermatol       Date:  1981-03       Impact factor: 9.302

7.  Oral methoxsalen photochemotherapy for the treatment of psoriasis: a cooperative clinical trial.

Authors:  J W Melski; L Tanenbaum; J A Parrish; T B Fitzpatrick; H L Bleich
Journal:  J Invest Dermatol       Date:  1977-06       Impact factor: 8.551

8.  Prevalence of nevocytic nevi on lateral and medial aspects of arms.

Authors:  A W Kopf; M Lazar; R S Bart; N Dubin; J Bromberg
Journal:  J Dermatol Surg Oncol       Date:  1978-02

9.  Nevi, lentigines, and melanomas in blacks.

Authors:  W P Coleman; L E Gately; A B Krementz; R J Reed; E T Krementz
Journal:  Arch Dermatol       Date:  1980-05

10.  Dysplastic nevus syndrome: a phenotypic association of sporadic cutaneous melanoma.

Authors:  D E Elder; L I Goldman; S C Goldman; M H Greene; W H Clark
Journal:  Cancer       Date:  1980-10-15       Impact factor: 6.860

View more
  3 in total

1.  Pigmentary traits, nevi and skin phototypes in a youth population of Central Italy.

Authors:  E Ballone; M Passamonti; G Lappa; G Di Blasio; P Fazii
Journal:  Eur J Epidemiol       Date:  1999-02       Impact factor: 8.082

2.  MelaNostrum: a consensus questionnaire of standardized epidemiologic and clinical variables for melanoma risk assessment by the melanostrum consortium.

Authors:  Alexander J Stratigos; Maria Concetta Fargnoli; Arcangela De Nicolo; Ketty Peris; Susana Puig; Efthymia Soura; Chiara Menin; Donato Calista; Paola Ghiorzo; Mario Mandala; Daniela Massi; Monica Rodolfo; Laura Del Regno; Irene Stefanaki; Helen Gogas; Veronique Bataille; Margaret A Tucker; David Whiteman; Eduardo Nagore; Maria Teresa Landi
Journal:  J Eur Acad Dermatol Venereol       Date:  2018-09-14       Impact factor: 6.166

3.  Accuracy in clinically evaluating pigmented lesions.

Authors:  R K Curley; M G Cook; M E Fallowfield; R A Marsden
Journal:  BMJ       Date:  1989-07-01
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.